Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc. Identifier:
First received: November 7, 2007
Last updated: February 17, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)